top of page

News

Discover what's happening at Retham. . .

Featured Milestone
Business Development

Retham Technologies Announces Initial Close of $1.5 Million Seed Financing to Advance HITDx™ Diagnostic for Heparin-Induced Thrombocytopenia

Company News and Recognition

July 2026
Curtis Jones presents: Off-The-Shelf Cryopreserved Platelets for Coagulation Research at ISTH2026

July 2026

Retham Partners with Prolytix as distributor for Retham CryoPlatelets

July 2025
Retham is awarded a $2.8M SBIR Phase IIb grant to develop an in-vitro diagnostic assay for Heparin-Induced Thrombocytopenia (HIT).

News Archive & Publications

bottom of page